RICHARDSON, Texas, Oct. 21 /PRNewswire/ -- Zyvex today announced financial results for its fiscal third quarter 2004. The Texas company continues its business gains with eight consecutive quarters of sales growth and expansion of its global sales reach. Executives anticipate that 2004's total revenue will exceed $8 million, which would represent a 90+ percent increase over 2003. "I continue to be extremely pleased with our financial results," stated Zyvex's CFO Timothy M. Gilmore. "During the month of September, we recorded our largest single month of customer orders booked, as well as net sales recorded." Founded in 1997, Zyvex reported its first revenues in 2001, grossing only $150,000. Company revenues grew to $1.2 million in 2002 and $4.5 million in 2003. Gilmore anticipates that the company will achieve cash-flow break-even by Q4 2005, and become bottom-line profitable in 2006. This announcement follows Zyvex's continued worldwide sales and marketing expansion into China, France, Germany, Italy, Japan, Korea, Malaysia, Poland, Singapore, Switzerland, Taiwan, Thailand, the United Kingdom, and Vietnam through alliances with Keithley Instruments, Inc., Caltron, Pte., and L.O.T.- Oriel. Zyvex also has numerous key alliances with industry leaders, including Easton Sports, FEI Company, Frost & Sullivan, MIT's Institute for Soldier Nanotechnologies, MANCEF, and many others. About the Company Zyvex Corporation, based in Richardson, Texas, is the first molecular nanotechnology company. Zyvex's vision is to be the leading worldwide supplier of tools, products, and services that enable adaptable, affordable, and molecularly precise manufacturing. Zyvex commercializes nanotechnology to address real-world applications with high growth potential. Zyvex carries its scientific breakthroughs into key commercial applications in the area of materials, tools, and structures for major markets serving Health Care, Life Sciences, Telecommunications, Aerospace, Semiconductors, and Defense customers.
SOURCE Zyvex Corporation